A Study of Letermovir (MK-8228) to Evaluate Efficacy and Safety for Prevention of Cytomegalovirus Infection in Chinese Hematopoietic Stem Cell Transplant Recipients (MK-8228-045)
Clinical trial NCT05763823 · COMPLETED
Trial details
- NCT number
- NCT05763823
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-24
- Primary completion
- 2024-04-18
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.